2010, Volume 3, Issue 3, pp 348 – 350

Pharmaceutical Industry in Syria

SCImago Journal & Country Rank

Issues

Special Issues

Authors and Affiliations

Correspondence to:Dirar Kutaini, M.D, 158 Ion Mihalache Street, Bucharest, Romania ,email: drkutaini@yahoo.co.uk

Abstract

The aim of this article is to present the development of the pharmaceutical industry in Syria using national and international public data sources. At the end of the 80ies, the pharmaceutical industry in Syria was very poor, covering 6% of the national needs. In less than 20 years, with the government support in terms of legal frame and strategic political engagement, the Syrian pharmaceutical industry finally covered almost 90% of the national needs, in terms of drugs, and exported drugs in around 52 Arabian countries. Beyond covering the local market, the main added values of this huge development consisted in exporting drugs in amount of 150 million dollars per year and providing jobs for 17000 Syrian people, out of which around 85% are women. Strong and weak points of the pharmaceutical sector are taken into consideration in the article and further interventions to support a sustainable development are proposed by the author.

Keywords

About this article

PMC ID: 3018990
PubMed ID: 20945828
DOI: 

Article Publishing Date (print): 15-08-2010
Available Online: 25-08-2010

Journal information

ISSN Printing: 1844-122X
ISSN Online: 1844-3117
Journal Title: Journal of Medicine and Life

Copyright License: Open Access

This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.


SCImago Journal & Country Rank

Issues

Special Issues